In addition, we genetically modified four MYCN-amplified neuroblastoma cells (SKNBE2, NB5, NBLS, and IMR-32) to express three different doxycycline-inducible shRNA that knock downed MYCN protein levels (Fig. 4B). Here, MYCN is linked to neuroblastoma.